Sodium Benzoate (SyneuRx)

苯甲酸钠 (SyneuRx)

Report date: 2025/06/05 20:00:13

Base Information

Drug NameSodium Benzoate (SyneuRx)
Drug Alias NameClozabenNaBenSND 51SND-14SND-13 +[7] 
ClassificationSmall molecules
Mechanisms of ActionD-amino-acid oxidase inhibitors
TargetsD-amino-acid oxidase
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyneurx International (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyneurx International (Taiwan) Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A